Akoya Biosciences, Inc.
SEC CIK 1711933 · AKYA · last insider filing 2025-07-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Shepler Robert G | Director | filed 2021 - 2025 |
| LAI Goldman Myla | Director | filed 2021 - 2025 |
| Schnettler Thomas P | Director | filed 2021 - 2025 |
| Raffin Thomas A. | Director | filed 2021 - 2025 |
| Mendel Scott | Director | filed 2021 - 2025 |
| Winkler Matthew | Director | filed 2021 - 2025 |
| Mckelligon Brian | Director · President/CEO | filed 2021 - 2025 |
| Nolan Garry Ph.D. | Director | filed 2021 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Ek John Frederick | Chief Financial Officer | filed 2023 - 2025 |
| Ramachandran Niro Ph.D | Chief Business Officer | filed 2021 - 2025 |
| Kamocsay Jennifer | General Counsel | filed 2023 - 2025 |
| Bamford Pascal | Chief Clinical Officer | filed 2024 - 2025 |
| Pla Frederic | Chief Operating Officer | filed 2021 - 2024 |
| Moy Marilee | Chief People Officer | filed 2022 - 2023 |
| El-Gabry Ehab | Chief Medical Officer | filed 2022 - 2023 |
| Driscoll Joseph | Chief Financial Officer | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.